Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LBPH | US
-0.18
-0.58%
Healthcare
Biotechnology
31/03/2024
02/07/2024
30.74
30.95
33.74
30.00
Longboard Pharmaceuticals Inc. a clinical-stage biopharmaceutical company focuses on developing novel and transformative medicines for neurological diseases. Its lead product candidate is LP352 which is in Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. The company's preclinical product candidate includes LP659 which focuses on developing therapies for multiple neurological diseases; and LP143. It also entered into license agreement with Arena Pharmaceuticals Inc. to develop and commercialize LP352 LP659 LP143 and other compounds. The company was formerly known as Arena Neuroscience Inc. and changed its name to Longboard Pharmaceuticals Inc. in October 2020. Longboard Pharmaceuticals Inc. was incorporated in 2020 and is based in La Jolla California.
View LessPositive Momentum
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Weakness based on declining price with high volume
High Short-term Volatility
High 6-Month Volatility (>65%)
High Current Volume and Negative 1-Day Return
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
115.3%1 month
98.6%3 months
84.6%6 months
455.2%-
-
18.24
0.01
0.01
-12.30
-
-
-62.90M
1.20B
1.20B
-
-
-
-
-30.04
15.31
14.30
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
15.20
Range1M
18.10
Range3M
18.10
Rel. volume
2.61
Price X volume
50.36M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
ANI Pharmaceuticals Inc | ANIP | Biotechnology | 62.64 | 1.31B | -1.26% | 39.55 | 68.66% |
Kiniksa Pharmaceuticals Ltd | KNSA | Biotechnology | 18.45 | 1.31B | 2.50% | 143.62 | 2.81% |
Verona Pharma plc | VRNA | Biotechnology | 15.46 | 1.25B | -0.32% | n/a | 22.79% |
immatics biotechnologies GmbH | IMTX | Biotechnology | 12.02 | 1.24B | 0.17% | n/a | 8.13% |
Ardelyx Inc | ARDX | Biotechnology | 5.28 | 1.24B | -30.25% | n/a | 69.54% |
Sana Biotechnology Inc. Common Stock | SANA | Biotechnology | 5.35 | 1.19B | -2.19% | n/a | 28.28% |
Day One Biopharmaceuticals Inc. Common Stock | DAWN | Biotechnology | 13.46 | 1.18B | -0.88% | n/a | 0.10% |
NRIX | NRIX | Biotechnology | 18.93 | 1.16B | -9.47% | n/a | 17.28% |
Prothena Corporation plc | PRTA | Biotechnology | 20.39 | 1.10B | -0.44% | n/a | 2.49% |
ARCUTIS BIOTHERAPEUTICS INC. | ARQT | Biotechnology | 9.3 | 1.08B | -2.72% | n/a | 91.91% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
REV Group Inc | REVG | Recreational Vehicles | 24.98 | 1.30B | 1.46% | 5.86 | 66.74% |
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 13.13 | 1.28B | 2.58% | n/a | 20.15% |
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.25 | 1.12B | 5.04% | n/a | -628.58% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 17.92 | 807.69M | 1.99% | n/a | 4070.84% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 33.09 | 676.35M | -2.01% | n/a | 4.21% |
Ennis Inc | EBF | Building Products & Equipment | 21.9 | 569.05M | 0.23% | 13.68 | 1.15% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 4.63 | 442.81M | 0.87% | n/a | 138.85% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 26.72 | 428.14M | 1.52% | n/a | 322.60% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.98 | 376.70M | 2.04% | 14.12 | 86.68% |
Latham Group Inc. | SWIM | Building Products & Equipment | 2.9 | 335.16M | 0.35% | 75.75 | 80.81% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -12.30 | -2.43 | Cheaper |
Ent. to Revenue | - | 4,101.76 | - |
PE Ratio | - | 41.26 | - |
Price to Book | 18.24 | 22.34 | Par |
Dividend Yield | - | 2.39 | - |
Std. Deviation (3M) | 84.65 | 76.52 | Par |
Debt to Equity | 0.01 | 0.51 | Cheaper |
Debt to Assets | 0.01 | 0.24 | Cheaper |
Market Cap | 1.20B | 3.77B | Emerging |